WMGI has been the subject of a number of other recent research reports. Analysts at Zacks reiterated a neutral rating on shares of Wright Medical in a research note to investors on Wednesday, February 27th. They now have a $24.00 price target on the stock. Separately, analysts at Leerink Swann upgraded shares of Wright Medical from a market perform rating to an outperform rating in a research note to investors on Tuesday, February 26th. Finally, analysts at Wunderlich raised their price target on shares of Wright Medical from $19.00 to $22.00 in a research note to investors on Friday, February 22nd. They now have a hold rating on the stock.
Seven research analysts have rated the stock with a buy rating, and eight have given a hold rating to the company’s stock. The company currently has an average rating of overweight and an average target price of $25.67.
Wright Medical traded down 0.04% on Tuesday, hitting $23.85. Wright Medical has a 1-year low of $17.28 and a 1-year high of $24.58. The stock’s 50-day moving average is currently $22.08. The company has a market cap of $927.5 million and a price-to-earnings ratio of 175.44.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.